{
  "id": 12663,
  "name": "Arpeggio Bio",
  "slug": "arpeggio-bio",
  "former_names": [
    "Arpeggio Biosciences"
  ],
  "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/254b79d146cf6fc4b70498fed074d6743d577e13.png",
  "website": "http://www.arpeggiobio.com",
  "all_locations": "Boulder, CO, USA",
  "long_description": "Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted \"undruggable\" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success. ",
  "one_liner": "Arpeggio Bio develops drugs targeting transcription factors using AIâ€¦",
  "team_size": 20,
  "industry": "Healthcare",
  "subindustry": "Healthcare -> Drug Discovery and Delivery",
  "launched_at": 1556764311,
  "tags": [
    "Biotech",
    "Genomics",
    "Drug discovery"
  ],
  "tags_highlighted": [],
  "top_company": false,
  "isHiring": false,
  "nonprofit": false,
  "batch": "Summer 2019",
  "status": "Active",
  "industries": [
    "Healthcare",
    "Drug Discovery and Delivery"
  ],
  "regions": [
    "United States of America",
    "America / Canada"
  ],
  "stage": "Early",
  "app_video_public": false,
  "demo_day_video_public": false,
  "app_answers": null,
  "question_answers": false,
  "url": "https://www.ycombinator.com/companies/arpeggio-bio",
  "api": "https://yc-oss.github.io/api/batches/summer-2019/arpeggio-bio.json"
}
